Explore more Johnson & Johnson sites:
In Season 2 of
The Road to a Vaccine
, host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.
Season 2, Episode 12
What We Now Know About How to Overcome COVID-19 in the U.S.
In the last episode of the year, Lisa Ling asks Taiwan’s former Vice President how the island has completely eliminated the disease. And Sean Penn and Ann Lee from the non-profit CORE talk about their efforts to fight COVID through improved testing.
Meet Our Host
Ling is the Executive Producer and host of
This Is Life
on CNN. She has also been a field correspondent for
The Oprah Winfrey Show
and a contributor to ABC News'
Nightline
.
Season 2, Episode 12: Expert Guest
Dr. Chen received his Sc.D. in epidemiology and human genetics from the Johns Hopkins University. He was appointed Minister of Department of Health, Minister of National Science Council and Vice President of Academia Sinica and was elected as the 14th Vice President of Republic of China (Taiwan).
Season 2, Episode 12: Expert Guest
Ann Lee
Ann Lee
Lee is the Chief Executive Officer of CORE (Community Organized Relief Effort), formerly J/P HRO, Sean Penn’s disaster relief charity, where she has overseen the successful transition from a Haiti-based recovery organization to an international response and resilience-building NGO. Previously, she worked at the UN’s Organization for Coordination and Humanitarian Affairs (OCHA). Lee is the author of
Livelihoods in Emergencies: A Double-Edged Sword
.
Season 2, Episode 12: Expert Guest
Sean Penn
Sean Penn
Penn is an Academy Award-winning actor, writer, producer, director and best-selling author. He is the co-founder of CORE (Community Organized Relief Effort), a non-profit dedicated to saving lives and strengthening communities affected by or vulnerable to crisis around the world which is currently focused on an integrated approach for COVID-19 relief effort across the country.
Season 2, Episode 12: J&J Expert Guest
Dr. Stoffels is the Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson. He spearheads the research and product pipeline by leading teams across all of the company's sectors to set the company-wide innovation agenda, discovering and developing transformational healthcare solutions.
On the final Season 2 episode of
The Road to a Vaccine
, host Lisa Ling delved into what it will take to overcome the pandemic in the U.S. Penn and Lee, two of the show's guests, shared what they've learned over the past nine months through their work helping provide testing across the country.
Season 2 Episodes
-
Season 2, Episode 1July 07, 2020How Lessons Learned in Fighting HIV Help Us Battle COVID-19How Lessons Learned in Fighting HIV Help Us Battle COVID-19In the Season 2 premiere, Lisa Ling checks into the virtual AIDS 2020 conference to talk with actress and HIV advocate Laverne Cox, Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., and others about the ongoing quest for an HIV vaccine and how that’s informing research on COVID-19 vaccines.
-
Season 2, Episode 2July 14, 2020How New COVID-19 Outbreaks Are Impacting a Global Return to NormalHow New COVID-19 Outbreaks Are Impacting a Global Return to NormalLisa Ling talks with Dr. Francis Collins, Director, NIH, about the latest on treatments and vaccines. Also, Harvard's Dr. Ashish Jha shares how the virus affects the body and Johns Hopkins' Dr. Tom Inglesby explains what the new data on spread means for people.
-
Season 2, Episode 3July 21, 2020How is COVID-19 Affecting Children? What Parents Worldwide Should KnowHow is COVID-19 Affecting Children? What Parents Worldwide Should KnowLisa Ling talks to UNICEF’s Henrietta Fore about global efforts to get all kids vaccinated. Harvard's Dr. Vikram Patel discusses children’s mental health during the pandemic. Plus, parents ask the experts their pressing questions about COVID-19.
-
Season 2 SpecialJuly 28, 2020Hear from the Experts: Is it Safe to Send Kids Back to School This Fall?Hear from the Experts: Is it Safe to Send Kids Back to School This Fall?In this bonus clip from “The Road to a Vaccine,” global public health experts weigh the risks—and benefits—of sending kids back to the classroom. Plus, the one frequently forgotten group that must be included in all decisions. Be sure to tune in for the next live episode of “The Road to a Vaccine, which returns August 18 at 12:00 PM ET.
-
Season 2 SpecialAugust 06, 2020Vaccines 101: How Do Clinical Vaccine Trials Work?Vaccines 101: How Do Clinical Vaccine Trials Work?In this Vaccines 101 bonus clip from “The Road to a Vaccine,” experts explain what happens during vaccine clinical trials and why these steps are crucial to ensuring vaccines are not just safe, but also effective. Also, be sure to tune in for the next live episode of “The Road to a Vaccine," which returns August 18 at 12:00 PM ET.
-
Season 2 SpecialAugust 11, 2020How Is COVID-19 Affecting Frontline Healthcare Workers and Their Families?How Is COVID-19 Affecting Frontline Healthcare Workers and Their Families?In this bonus clip from “The Road to a Vaccine,” Thrive Global's Arianna Huffington and others discuss the pressures on frontline healthcare workers that come with battling this pandemic. Also, doctors and nurses themselves share some of the rewarding moments they’ve had while working to save lives. Be sure to tune in for the next live episode of “The Road to a Vaccine," which returns August 18 at 12:00 PM ET.
-
Season 2, Episode 4August 18, 2020How Healthcare Advocates Are Changing the Global Conversation about COVID-19How Healthcare Advocates Are Changing the Global Conversation about COVID-19In this week’s episode of “The Road to a Vaccine,” Lisa Ling talks with scientific journalists, healthcare experts and others about the role of social movements—both in the past and today with the COVID-19 pandemic—in driving access to care, building critical disease awareness and more. Guests include journalist David France, Dr. Sudip Parikh, CEO of the American Association for the Advancement of Science, Mary Woolley, President and CEO of grassroots health organization Research!America and Seema Kumar, Vice President, Innovation, Global Health and Science Policy Communication at Johnson & Johnson.
-
Season 2 SpecialAugust 25, 2020Why Racial Disparities in Healthcare Make COVID-19’s Impact Worse for Minorities | Johnson & JohnsonWhy Racial Disparities in Healthcare Make COVID-19’s Impact Worse for Minorities | Johnson & Johnson
-
Season 2 SpecialSeptember 01, 2020Why Trusting Science Right Now is More Important Than EverWhy Trusting Science Right Now is More Important Than Ever
-
Season 2, Episode 5September 08, 2020What Have We Learned After Eight Months of COVID-19?What Have We Learned After Eight Months of COVID-19?Lisa Ling asks health experts for a pandemic status report, including the latest statistics on cases worldwide, the current thinking about coronavirus and its effects and what’s working to fight the disease—and what’s not.
-
Season 2, Episode 6September 15, 2020Everything You Need to Know about COVID-19 Testing and Contact TracingEverything You Need to Know about COVID-19 Testing and Contact TracingAs we head into fall, how is COVID-19 testing going? Lisa Ling speaks to experts—including Ann Lee, co-founder, with actor Sean Penn, of the nonprofit CORE—to get the latest updates on testing efforts and contact tracing across America.
-
Season 2, Episode 7September 22, 2020Is It Really Safe for Schools to Be Open Right Now?Is It Really Safe for Schools to Be Open Right Now?As schools reopen—and sometimes close again—what have we learned about the risks of in-person learning? Lisa Ling speaks to school nurse Robin Cogan and pediatrician Dr. Sam Maldonado to find answers and debunk myths around kids and COVID-19.
-
Season 2, Episode 8October 06, 2020A New York City Doctor Shares What He’s Learned About COVID-19A New York City Doctor Shares What He’s Learned About COVID-19Dr. Matt McCarthy shares with Lisa Ling how he believes mask wearing, social distancing and good science have helped lower COVID-19 rates in NYC. And Dr. Paul Stoffels gives an update on the scientific community's latest coronavirus news.
-
Season 2 SpecialOctober 13, 2020How is COVID-19 Affecting Our Mental Health—and What Can We Do About It?How is COVID-19 Affecting Our Mental Health—and What Can We Do About It?Whether you’re a frontline healthcare worker or a parent working from home, the pandemic has caused anxiety, stress and fear around the world. Learn what you can do to address these mental challenges, plus, how to know if your child needs help right now.
-
Season 2, Episode 9October 20, 2020Experts Weigh In On COVID-19 Testing, Vaccine Trials and MoreExperts Weigh In On COVID-19 Testing, Vaccine Trials and MoreLisa Ling speaks with Dr. Paul Stoffels on the latest coronavirus vaccine developments. Dr. Cato Laurencin discusses why it’s critical to have diversity in clinical trials. Plus, news on possible breakthroughs in COVID-19 diagnostic testing.
-
Season 2, Episode 10October 26, 2020The Very Latest News on COVID-19 Tests and TreatmentsThe Very Latest News on COVID-19 Tests and TreatmentsWhat are COVID-19’s long-term effects? And how do we overcome healthcare disparities, the misuse of scientific data and other obstacles in the fight against the pandemic? Lisa Ling asks experts like Nurse Alice Benjamin and Dr. Eric Topol.
-
Season 2 SpecialNovember 05, 2020Why People of All Colors and Ages Are Crucial to Vaccine Clinical TrialsWhy People of All Colors and Ages Are Crucial to Vaccine Clinical TrialsExperts explain why recruiting clinical trial participants from diverse backgrounds around the world—young, old, Black, brown, Indigenous and more—is critical to developing a potential COVID-19 vaccine.
-
Season 2, Episode 11November 10, 2020How 3 Brilliant Women Are Changing the Game When It Comes to COVID-19How 3 Brilliant Women Are Changing the Game When It Comes to COVID-19Lisa Ling speaks to Dr. Uché Blackstock about the racial inequities the pandemic has exposed, Dr. Alison Schwartz about battling a COVID-19 spike in Wisconsin and 14-year-old Anika Chebrolu about her prize-winning potential coronavirus therapy.
-
Season 2 SpecialNovember 17, 2020The Best Ways to Protect Yourself—and Others—From COVID-19The Best Ways to Protect Yourself—and Others—From COVID-19With the holidays coming soon, the U.S. is seeing its highest number of novel coronavirus cases to date. Dr. Alison Schwartz and Johnson & Johnson’s Dr. Paul Stoffels share tips on staying protected and quarantining effectively.
-
Season 2, Episode 12November 30, 2020What We Now Know About How to Overcome COVID-19 in the U.S.What We Now Know About How to Overcome COVID-19 in the U.S.In the last episode of the year, Lisa Ling asks Taiwan’s former Vice President how the island has completely eliminated the disease. And Sean Penn and Ann Lee from the non-profit CORE talk about their efforts to fight COVID through improved testing.
Season 1 Episodes
-
Season 1, Episode 1April 14, 2020How a COVID-19 Vaccine Might Work. Plus, How Quickly We Could Get ThereHow a COVID-19 Vaccine Might Work. Plus, How Quickly We Could Get ThereJoin host Lisa Ling as she interviews scientists and healthcare workers about how vaccines work, the impact of the COVID-19 pandemic and what’s being done globally to create a novel coronavirus vaccine.
-
Season 1, Episode 2April 21, 2020What it Takes to Create a Coronavirus Vaccine in Record TimeWhat it Takes to Create a Coronavirus Vaccine in Record TimeThree leading scientists who have been on the frontlines of Zika, malaria and HIV give you the inside scoop on vaccine development and the process of going from lab to clinic.
-
Season 1, Episode 3April 28, 2020Why is COVID-19 Hitting Minority Communities So Hard?Why is COVID-19 Hitting Minority Communities So Hard?Lisa Ling interviews National Academies member and University Professor at the University of Connecticut, Cato Laurencin, M.D., Ph.D., to learn what his new coronavirus study reveals. Plus, what’s needed to mass-produce a vaccine and what we’ve learned from other outbreaks.
-
Season 1, Episode 4May 05, 2020What Doctors On The Front Lines of COVID-19 Are Now Saying About the VirusWhat Doctors On The Front Lines of COVID-19 Are Now Saying About the VirusThis week we hear from two ER doctors about what they’ve learned from caring for COVID-19 patients. A renowned epidemiologist shares why testing is so important. A Nigerian doctor who recovered from Ebola herself talks about how fighting this outbreak is different. Plus, a leading scientist talks about how long vaccine immunity could last.
-
Season 1, Episode 5May 12, 2020How Nurses Are Battling the COVID-19 PandemicHow Nurses Are Battling the COVID-19 PandemicTwo nurses—one on the front lines in the ICU, and one leading the charge to advocate for her profession—talk about what caring for patients, and each other, really means right now. An activist talks about recovering from the virus and a scientist shares the challenges of creating a vaccine for clinical. Plus, Arianna Huffington and Husseini K. Manji, MD, FRCPC, discuss the other COVID-19 crisis: how it's impacting mental health.
-
Season 1, Episode 6May 19, 2020How the Global Community is Coming Together to Battle COVID-19How the Global Community is Coming Together to Battle COVID-19In Episode 6, Ling talks with Jane Halton, Chair of the Coalition for Epidemic Preparedness Innovations, about her work to ensure people globally get access to vaccines. Seema Kumar, Vice President, Innovation, Global Health and Science Policy Communication, discusses the challenges of fighting the pandemic. Plus, Janssen supply chain expert Remo Colarusso explains what it takes to get vaccines from the lab and into health workers' hands, and Laura Lane, President of Global Public Affairs at UPS, talks about the logistics of shipping during a pandemic. We also hear from youth advocate Adefare Tomisin Elizabeth on how she's educating people about the virus in remote areas of Nigeria.
-
Season 1, Episode 7May 26, 2020What Our “New Normal” Might Look Like Until We Get a COVID-19 VaccineWhat Our “New Normal” Might Look Like Until We Get a COVID-19 VaccineIn Episode 7, Lisa Ling speaks with Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., about important advances being made in vaccine development. Former FDA Commissioner Mark McClellan, M.D., Ph.D., discusses what reopening could look like and global health leader Jonathan Quick, M.D., MPH, shares why he believes testing is critical to help manage this pandemic.
-
Season 1, Episode 8June 02, 2020In the season finale of The Road to a Vaccine, pandemic pioneers Paul Stoffels, M.D., and Peter Piot, M.D., Ph.D., discuss Dr. Piot’s own experience battling COVID-19. Cato Laurencin, M.D., Ph.D., a world-renowned physician and healthcare leader weighs in on how racism is a public health crisis and discusses the impact of recent protests in the midst of a pandemic. Plus, Lisa Ling talks with International Rescue Committee President and CEO Rt Hon David Miliband about how to protect refugees and other groups particularly vulnerable to the effects of the novel coronavirus.
-
What People Are Saying
Thank you for your insight and information. A clear beacon of sensibility which is very welcome at the moment.
Amazing & great explanation of the development of a vaccine in a succinct way. Many thanks, Dr. Mathai.
Excellent interview! Dr. Stoffels = Terrific!
Amazing job from Laverne Cox and a big THANK YOU for sharing your knowledge and experienced perspective! I happily watched the number of viewers rise.
Excellent speakers. It gives a good perspective on what the nurses are dealing with. Thank you!
Such an awesome episode!! Great panelists!!! Happy Nurses day to all nurses, especially my sister!!!
Glad to see how leaders from J&J are supporting front liners, which is an incredible example of serving community as a first priority. Many thanks.
Wonderful guests—thank you!
Thank you Lisa for doing these interviews and the J&J team for providing this information. Your calm, thoughtful approach to covering these complex multi-dimensional issues is so appreciated.🌼
Best wishes, Dr. Schuitemaker. Thanks for all the hard work, conducting number of trial activities in parallel and collaborating across the industry.
Appreciate all the hard work of our scientists, sacrificing so much of their time. You guys are heroes!
Amazing, we value your countless contributions to saving lives.
Looking forward to tuning in to tomorrow's episode. Appreciate these very informative sessions. Thanks, Lisa!
It is really brilliant to see that Johnson and Johnson are gearing up for production worldwide for the vaccines once approved by PHE.
I love my company, worked a lot of years being an inspector. Miss not working, I'm retired now. They will find a vaccine.
The Human Genome Project began with the same spirit. Well done J&J for reviving that collaborative working.
-
Submit a QuestionDo you have a question that you would like to have answered on an upcoming episode of The Road to a Vaccine?